IL-6 and TNF-α that are robustly high during COVID-19 have been linked to reduced BMPR2 expression [132] and associated with severe disease and death in patients with pulmonary arterial hypertension (PAH) [133–136]. Here, IL6 is linked to pulmonary arterial hypertension.